PARKHOSPS

Park Medi World Limited

Multi-super-specialty hospital chain offering tertiary and quaternary care

Healthcare›Healthcare›Healthcare Services›Hospital

parkhospital.in

Ask AI

Key metrics

Price as of 2026-10-19

Stock price

₹227.85

Market cap

9,842 Cr

Stock P/E

38.1 · FY26

P/B

4.87

ROE (FY26)

12.3%

ROCE (FY26)

17.7%

Operating margin (FY26)

22.7%

Debt / equity (FY26)

0.11

OCF / EBITDA (FY26)

74.1%

OCF / EBITDA (3Y)

78.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Park Hospitals (Park Medi World) runs a chain of multi-super-specialty hospitals in northern India that treats mainly patients covered by government insurance schemes, at relatively affordable prices.

Company snapshot

11thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives

✓Net margin of 16.3% — the business keeps a healthy share of every rupee it earns.

1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Dec 2025	Mar 2026	Jun 2026
Sales	410 Cr	460 Cr	476 Cr
Operating expenses (approx.)	311 Cr	333 Cr	350 Cr
EBITDA	99 Cr	127 Cr	126 Cr
OPM %	24.2%	27.7%	26.5%
Other income	9 Cr	8 Cr	8 Cr
Interest	15 Cr	14 Cr	10 Cr
Depreciation	15 Cr	18 Cr	19 Cr
Profit before tax	78 Cr	103 Cr	105 Cr
Tax %	32.5%	25.7%	15.7%
Net profit	53 Cr	77 Cr	89 Cr
EPS (₹)	₹1.35	₹1.78	₹2.05

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,255 Cr	1,231 Cr	1,394 Cr	1,679 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	864 Cr	921 Cr	1,021 Cr	1,235 Cr	Sign in free for the trailing twelve months
EBITDA	390 Cr	310 Cr	372 Cr	444 Cr	Sign in free for the trailing twelve months
OPM %	31.1%	25.2%	26.7%	26.5%	Sign in free for the trailing twelve months
Other income	18 Cr	32 Cr	32 Cr	32 Cr	Sign in free for the trailing twelve months
Interest	51 Cr	70 Cr	60 Cr	59 Cr	Sign in free for the trailing twelve months
Depreciation	41 Cr	51 Cr	58 Cr	62 Cr	Sign in free for the trailing twelve months
Profit before tax	315 Cr	218 Cr	287 Cr	355 Cr	Sign in free for the trailing twelve months
Tax %	27.6%	30.3%	25.6%	22.9%	Sign in free for the trailing twelve months
Net profit	228 Cr	152 Cr	213 Cr	274 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹5.94	₹3.95	₹5.55	₹6.87	Sign in free for the trailing twelve months
Dividend payout %	—	—	—	0.0%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	77 Cr	77 Cr	77 Cr	86 Cr
Reserves	610 Cr	806 Cr	993 Cr	1,936 Cr
Borrowings	557 Cr	633 Cr	622 Cr	228 Cr
Other liabilities	306 Cr	344 Cr	385 Cr	481 Cr
Total liabilities	1,593 Cr	1,912 Cr	2,134 Cr	2,813 Cr
Fixed assets (net)	440 Cr	707 Cr	764 Cr	788 Cr
CWIP	5 Cr	32 Cr	37 Cr	123 Cr
Investments	—	0.09 Cr	0.09 Cr	0.13 Cr
Inventories	2 Cr	2 Cr	3 Cr	3 Cr
Trade receivables	576 Cr	511 Cr	614 Cr	593 Cr
Cash & bank	100 Cr	77 Cr	103 Cr	237 Cr
Other assets	469 Cr	583 Cr	614 Cr	1,069 Cr
Total assets	1,593 Cr	1,912 Cr	2,134 Cr	2,813 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	195 Cr	361 Cr	191 Cr	329 Cr
Cash from investing	-180 Cr	-255 Cr	-91 Cr	-333 Cr
Cash from financing	2 Cr	-130 Cr	-74 Cr	121 Cr
Net cash flow	17 Cr	-23 Cr	26 Cr	116 Cr
Free cash flow (OCF − Capex)	97 Cr	290 Cr	32 Cr	209 Cr

Ratios

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	28.4%	18.4%	19.8%	17.7%
ROE %	30.1%	16.4%	18.2%	12.3%
Debtor days	167	151	160	129
Inventory days	3	3	3	4
Days payable	112	134	175	134
Cash conversion cycle	59	21	-12	-2
OCF / EBITDA %	50.0%	116.5%	51.4%	74.1%
OCF / EBITDA % (3 years)	—	—	69.7%	78.2%
Debt / equity	0.81	0.72	0.58	0.11
Current ratio	1.57	1.79	1.86	2.06
Net debt / EBITDA	1.17	1.79	1.40	-0.02